EUVIMEDEUVIMED entdecken
Crossref

1G6 ‐ D7 Inhibits Homologous Recombination Repair by Targeting Extracellular HSP90α to Promote Apoptosis in Non–Small Cell Lung Cancer

Jiangzhou Du, Jinming Zhang, Dongyu Liu, Lin Gao, Hua Liao, Lanhe Chu, Jie Lin, Wei Li, Xiaojing Meng, Fei Zou, Shaoxi Cai, Mengchen Zou und 1 weitere

Environmental Toxicology · 2024

DOI: 10.1002/tox.24356 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Environmental Toxicology, 2024. Verfasst von Jiangzhou Du und 12 weiteren Autor:innen. Beteiligte Einrichtung: Chronic Airways Diseases Laboratory, Department of Respiratory and Critical Care Medicine, Nanfang Hospital, Southern Medical University, Guangzhou, …. Hauptthemen laut MEDLINE: Recombinational DNA Repair, Carcinoma, Non-Small-Cell Lung, Antibodies, Monoclonal, Lung Neoplasms. Die Arbeit nennt 52 Literaturangaben. Gefördert von: National Natural Science Foundation of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Despite recent advances in treatment, non–small cell lung cancer (NSCLC) continues to have a high mortality rate. Currently, NSCLC pathogenesis requires further investigation, and therapeutic drugs are still under development. Homologous recombination repair (HRR) repairs severe DNA double‐strand breaks. Homologous recombination repair deficiency (HRD) occurs when HRR is impaired and causes irreparable double‐strand DNA damage, leading to genomic instability and increasing the risk of cancer development. Poly(ADP‐ribose) polymerase (PARP) inhibitors can effectively treat HRD‐positive tumors. Extracellular heat shock protein 90α (eHSP90α) is highly expressed in hypoxic environments and inhibits apoptosis, thereby increasing cellular tolerance. Here, we investigated the relationship between eHSP90α and HRR in NSCLC. DNA damage models were established in NSCLC cell lines (A549 and H1299). The activation of DNA damage and HRR markers, apoptosis, proliferation, and migration were investigated. In vivo tumor models were established using BALB/c nude mice and A549 cells. We found that human recombinant HSP90α stimulation further activated HRR and reduced DNA damage extent; however, eHSP90α monoclonal antibody, 1G6‐D7, effectively inhibited HRR. HRR inhibition and increased apoptosis were observed after LRP1 knockdown; this effect could not be reversed with hrHSP90α addition. The combined use of 1G6‐D7 and olaparib caused significant apoptosis and HRR inhibition in vitro and demonstrated promising anti‐tumor effects in vivo. Extracellular HSP90α may be involved in HRR in NSCLC through LRP1. The combined use of 1G6‐D7 and PARP inhibitors may exert anti‐tumor effects by inhibiting DNA repair and further inducing apoptosis of NSCLC cells.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Recombinational DNA RepairCarcinoma, Non-Small-Cell LungAntibodies, MonoclonalLung NeoplasmsAntineoplastic AgentsHumansCell Line, TumorBleomycinHydrogen PeroxideDNA DamageHSP90 Heat-Shock ProteinsApoptosisAnimalsMiceMice, NudeMice, Inbred BALB CCell ProliferationDrug CombinationsPhthalazinesPiperazines

Stichwörter der Autor:innen

1G6‐D7DNA damageNSCLCeHSP90αhomologous recombination repair

Substanzen

Antibodies, MonoclonalBleomycinHydrogen PeroxideHSP90 Heat-Shock ProteinsolaparibAntineoplastic AgentsDrug CombinationsPhthalazinesPiperazines

Autor:innen und Institutionen

  • Chronic Airways Diseases Laboratory, Department of Respiratory and Critical Care Medicine, Nanfang Hospital, Southern Medical University, Guangzhou, China.
  • Department of Pathology, School of Basic Medical Sciences, Southern Medical University, Guangzhou, China.
  • Department of Dermatology, The USC-Norris Comprehensive Cancer Center, University of Southern California Keck Medical Center, California, Los Angeles, USA.
  • Department of Occupational Health and Occupational Medicine, Guangdong Provincial Key Laboratory of Tropical Disease Research, School of Public Health, Southern Medical University, Guangzhou, China.
  • Department of Endocrinology and Metabolism, Nanfang Hospital, Southern Medical University, Guangzhou, China.

ORCID-Profile: Hangming Dong

Förderung

  • National Natural Science Foundation of China

Zitieren

APA

Du, J., Zhang, J., Liu, D., Gao, L., Liao, H., Chu, L., Lin, J., Li, W., Meng, X., Zou, F., Cai, S., Zou, M., & Dong, H. (2024). 1G6 ‐ D7 Inhibits Homologous Recombination Repair by Targeting Extracellular HSP90α to Promote Apoptosis in Non–Small Cell Lung Cancer. Environmental Toxicology. https://doi.org/10.1002/tox.24356

Vancouver

Du J, Zhang J, Liu D, Gao L, Liao H, Chu L, et al. 1G6 ‐ D7 Inhibits Homologous Recombination Repair by Targeting Extracellular HSP90α to Promote Apoptosis in Non–Small Cell Lung Cancer. Environmental Toxicology. 2024. doi:10.1002/tox.24356

BibTeX
@article{Du2024,
  author = {Du, Jiangzhou and Zhang, Jinming and Liu, Dongyu and Gao, Lin and Liao, Hua and Chu, Lanhe and Lin, Jie and Li, Wei and Meng, Xiaojing and Zou, Fei and Cai, Shaoxi and Zou, Mengchen and Dong, Hangming},
  title = {1G6 ‐ D7 Inhibits Homologous Recombination Repair by Targeting Extracellular HSP90α to Promote Apoptosis in Non–Small Cell Lung Cancer},
  journal = {Environmental Toxicology},
  year = {2024},
  doi = {10.1002/tox.24356}
}
Kostenlos starten →